Criteria for Diagnosics of Central Serous Chorioretinopathy

Andrey G. Shchuko, Anna N. Zlobina, Tatiana N. Jureva


Key words: central serous chorioretinopathy, detachment of retinal neuroepithelium, detachment of the retinal pigment epithelium, classification.


Annotation: Actuality. The common classification of central serous chorioretinopathy (CSCR), based on the presence or absence of leakage point fluorescein according to fluorescent angiography, does not reflect the true picture of the disease and not allows according only this criterion defining the algorithm of therapeutic measures and functional prognosis of the disease.  

Purpose. To optimize CSCR diagnostic criteria defining the strategy of therapeutic measures and functional prognosis of the disease.

Materials and methods. A complete ophthalmological and physical examination of 101 men with central serous chorioretinopathy were made.

Results. Comparative analysis of the results of ophthalmic status examination, data of color Doppler mapping of orbital vessels, certain hormones that characterize metabolic processes and indices that reflect the degree of endothelial dysfunction, allowed distinguishing 3 clinical forms of the disease, the main criterion of their division served the area of destruction of pigment epithelium.

1. CSCR with local damage of pigment epithelium (with leakage point); 2. CSCR with extensive damage of the pigment epithelium with diffuse leakage; 3. CSCR with extensive damage of the pigment epithelium in conjunction with leakage point (recurrence of leakage). The criterion for determining the resistance to any kind of treatment is the combined change in retinal interface, accompanied by the formation of detachment not only neuro-, but the retinal pigment epithelium.

Conclusion. Development of new classification criteria of the disease allows already at the stage of diagnosis more accurately constructing an algorithm of therapeutic measures and determining the and prognosis of CSCR.


PDF (English)


Gass JD. Central serous chorioretinopathy and white subretinal exudation during pregnancy: Arch Ophthalmol, 1991, 109; 677–681.

Guyer DR, Yannuzzi LA, Slakter JS. et al. Digital indocyanine green videoangiography of central serous chorioretinopathy: Arch. Ophthalmol, 1994, 112; 1057–1062.

Iida T, Kishi S, Hagimura N. et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina, 1999, 19; 508–512.

Imamura Y, Fujiwara T, Margolis R. et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina, 2009, 29; 1469–1473.

Katznelson LA, Morozova TI, Bunin AY. Vascular diseases of the eye. Moscow, Medicine, 1990; 193.

Marmor MF. New hypothesis on the pathogenesis and treatment of serous retinal detachment: Graefes Arch. Clin. Exp. Ophthalmol, 1988, 226; 548–552.

Moschos M, Brouzas D, Koutsandrea C. et al. Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography. Ophthalmologica, 2007, 221 (5); 292–298.

Sekiryu T, Iida T, Maruko I. et al. Infrared Fundus Autofluorescence and Central Serous Chorioretinopathy; Investigative Ophthalmology & Visual Science, 2010, 51(10); 4956–4962.

Shchuko AG, Zlobina AN, Iureva TN. Etiopathogenic approaches to diagnostics and treatment of acute and chronic central serous chorioretinopathy: Ophthalmology, 2013, 2; 14-19.

Shchuko AG, Malyshev VV. Optic coherence tomography in diagnostics of ocular diseases. Moscow, GEOTAR-MEDIA, 2010; 128.

Shchuko AG, Zhukova TN, Iureva TN. Ultrasound diagnostics in ophthalmology. Moscow, Ophthalmology, 2013; 128.

Clinical Endocrinology: a guide: N.T. Srakova. 3rd edition. Saint-Petersburg, Piter, 2002; 576.

Veljkov VV. C-reactive protein in the laboratory diagnostics of acute inflammation and in the assessment of risk of vascular pathologies: Clinical laboratory consultation, 2008, 2 (21); 37-48.

Volkova NV, Kazakov YV, Malyshev VV. The syndrome of "endogenous inflammation" as the most important factor in the formation of invalidity of pathways of intraocular fluid outflow after fistulizing antiglaucomatous surgery: Bulletin ESSC SB RAMS, 2011, 6; 20-24.

Zlobina AN, Iureva TN. Central serous chorioretinopathy: Laser surgery of vascular pathology of fundus: Ed AG. Shchuko. Moscow, Ophthalmology, 2014; 158-175.

Yannuzzi LA. Type A behavior and central serous chorioretinopathy: Trans. Am. Ophthalmol. Soc, 1986, 84; 799–845.


  • Im Moment gibt es keine Refbacks